Cite
McCoull W, Hennessy EJ, Blades K, et al. Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors. ACS Med Chem Lett. 2016;7(12):1118-1123doi: 10.1021/acsmedchemlett.6b00322.
McCoull, W., Hennessy, E. J., Blades, K., Chuaqui, C., Dowling, J. E., Ferguson, A. D., Goldberg, F. W., Howe, N., Jones, C. R., Kemmitt, P. D., Lamont, G., Varnes, J. G., Ward, R. A., & Yang, B. (2016). Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors. ACS medicinal chemistry letters, 7(12), 1118-1123. https://doi.org/10.1021/acsmedchemlett.6b00322
McCoull, William, et al. "Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors." ACS medicinal chemistry letters vol. 7,12 (2016): 1118-1123. doi: https://doi.org/10.1021/acsmedchemlett.6b00322
McCoull W, Hennessy EJ, Blades K, Chuaqui C, Dowling JE, Ferguson AD, Goldberg FW, Howe N, Jones CR, Kemmitt PD, Lamont G, Varnes JG, Ward RA, Yang B. Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors. ACS Med Chem Lett. 2016 Sep 14;7(12):1118-1123. doi: 10.1021/acsmedchemlett.6b00322. eCollection 2016 Dec 08. PMID: 27994749; PMCID: PMC5150691.
Copy
Download .nbib